-+ 0.00%
-+ 0.00%
-+ 0.00%

KAILERA THERAPEUTICS - TOPLINE DATA FROM KAINETIC PHASE 3 TRIALS EXPECTED IN MID-2028

Reuters·09/30/2026 11:02:59